Mass spectrometry-based quantification of myocardial protein adducts with acrolein in an in vivo model of oxidative stress

Molecular Nutrition and Food Research

Volumn 55, Issue 9, 2011, Pages 1401-1410

  Wu, Jianyong ^a   Stevens, Jan F ^b   Maier, Claudia S ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Acrolein; Aldehyde keto reactive probe; Mitochondria; Protein carbonyls; Selected reaction monitoring

Indexed keywords

ACROLEIN; ADENINE NUCLEOTIDE TRANSLOCASE; CHLOROFORM; MALATE DEHYDROGENASE; MITOCHONDRIAL PROTEIN; PEPTIDE; PROTEOME;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; DISEASE MODEL; FISCHER 344 RAT; HEART MITOCHONDRION; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; OXIDATIVE STRESS; RAT; TANDEM MASS SPECTROMETRY;

ACROLEIN; AMINO ACID SEQUENCE; ANIMALS; CHLOROFORM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; MALATE DEHYDROGENASE; MALE; MITOCHONDRIA, HEART; MITOCHONDRIAL ADP, ATP TRANSLOCASES; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; OXIDATIVE STRESS; PEPTIDES; PROTEOME; RATS; RATS, INBRED F344; TANDEM MASS SPECTROMETRY;

RATTUS;

EID: 80052518807     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100255     Document Type: Article

References (48)

1. Faroon, O., Roney, N., Taylor, J., Ashizawa, A. et al., Acrolein health effects. Toxicol. Ind. Health 2008, 24, 447-490.
2. Stevens, J. F., Maier, C. S., Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52, 7-25.
3. Minko, I. G., Kozekov, I. D., Harris, T. M., Rizzo, C. J. et al., Chemistry and biology of DNA containing 1, N(2)-deoxyguanosine adducts of the alpha, beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem. Res. Toxicol. 2009, 22, 759-778.
4. Uchida, K., Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc. Med. 1999, 9, 109-113.
5. LoPachin, R. M., Gavin, T., Petersen, D. R., Barber, D. S., Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem. Res. Toxicol. 2009, 22, 1499-1508.
6. Custovic, Z., Zarkovic, K., Cindric, M., Cipak, A. et al., Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery. Free Radic. Res. 2010, 44, 497-504.
7. Srivastava, S., Sithu, S. D., Vladykovskaya, E., Haberzettl, P. et al., Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 2011, 215, 301-308.
8. Hamann, K., Shi, R., Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury. J. Neurochem. 2009, 111, 1348-1356.
9. Bradley, M. A., Markesbery, W. R., Lovell, M. A., Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic. Biol. Med. 2010, 48, 1570-1576.
10. Zarkovic, K., Uchida, K., Kolenc, D., Hlupic, L., Zarkovic, N., Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic. Res. 2006, 40, 543-552.
11. Shi, Y., Sun, W., McBride, J. J., Cheng, J.-X., Shi, R., Acrolein induces myelin damage in mammalian spinal cord. J. Neurochem. 2011, 117, 554-564.
12. Luo, J., Hill, B. G., Gu, Y., Cai, J. et al., Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H3673-H3684.
13. Sayre, L. M., Lin, D., Yuan, Q., Zhu, X., Tang, X., Protein adducts generated from products of lipid oxidation: focus on HNE and one. Drug Metab. Rev. 2006, 38, 651-675.
14. Stadtman, E. R., Protein oxidation in aging and age-related diseases. Ann. NY Acad. Sci. 2001, 928, 22-38.
15. Lund, M. N., Heinonen, M., Baron, C. P., Estévez, M., Protein oxidation in muscle foods: a review. Mol. Nutr. Food Res. 2011, 55, 83-95.
16. Levine, R. L., Garland, D., Oliver, C. N., Amici, A. et al., Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186, 464-478.
17. Korolainen, M. A., Goldsteins, G., Alafuzoff, I., Koistinaho, J., Pirttila, T., Proteomic analysis of protein oxidation in Alzheimer's disease brain. Electrophoresis 2002, 23, 3428-3433.
18. Reinheckel, T., Korn, S., Mohring, S., Augustin, W. et al., Adaptation of protein carbonyl detection to the requirements of proteome analysis demonstrated for hypoxia/reoxygenation in isolated rat liver mitochondria. Arch. Biochem. Biophys. 2000, 376, 59-65.
19. Ichihashi, K., Osawa, T., Toyokuni, S., Uchida, K., Endogenous formation of protein adducts with carcinogenic aldehydes. J. Biol. Chem. 2001, 276, 23903-23913.
20. Roeser, J., Bischoff, R., Bruins, A., Permentier, H., Oxidative protein labeling in mass-spectrometry-based proteomics. Anal. Bioanal. Chem. 2010, 397, 3441-3455.
21. Chavez, J., Wu, J., Han, B., Chung, W. G., Maier, C. S., New role for an old probe: affinity labeling of oxylipid protein conjugates by N'-aminooxymethylcarbonylhydrazino d-biotin. Anal. Chem. 2006, 78, 6847-6854.
22. Barnes, S., Shonsey, E. M., Eliuk, S. M., Stella, D. et al., High-resolution mass spectrometry analysis of protein oxidations and resultant loss of function. Biochem. Soc. Trans. 2008, 36, 1037-1044.
23. Roede, J. R., Carbone, D. L., Doorn, J. A., Kirichenko, O. V. et al., In vitro and in silico characterization of peroxiredoxin 6 modified by 4-hydroxynonenal and 4-oxononenal. Chem. Res. Toxicol. 2008, 21, 2289-2299.
24. Roe, M. R., Xie, H., Bandhakavi, S., Griffin, T. J., Proteomic mapping of 4-hydroxynonenal protein modification sites by solid-phase hydrazide chemistry and mass spectrometry. Anal. Chem. 2007, 79, 3747-3756.
25. Han, B., Stevens, J. F., Maier, C. S., Design, synthesis, and application of a hydrazide-functionalized isotope-coded affinity tag for the quantification of oxylipid-protein conjugates. Anal. Chem. 2007, 79, 3342-3354.
26. Madian, A. G., Regnier, F. E., Proteomic identification of carbonylated proteins and their oxidation sites. J. Proteome Res. 2010, 9, 3766-3780.
27. Madian, A. G., Regnier, F. E., Profiling carbonylated proteins in human plasma. J. Proteome Res. 2010, 9, 1330-1343.
28. Codreanu, S. G., Zhang, B., Sobecki, S. M., Billheimer, D. D., Liebler, D. C., Global Analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol. Cell. Proteomics 2009, 8, 670-680.
29. Maier, C. S., Chavez, J., Wang, J., Wu, J. et al., Methods Enzymology, Academic Press, New York pp. 305-330.
30. Carini, M., Aldini, G., Facino, R. M., Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mass Spectrom Rev. 2004, 23, 281-305.
31. Orioli, M., Aldini, G., Benfatto, M. C., Maffei Facino, R., Carini, M., HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines:LC MS/MS profiling in Zucker Obese rats. Anal. Chem. 2007, 79, 9174-9184.
32. Held, J. M., Danielson, S. R., Behring, J. B., Atsriku, C. et al., Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry approach. Mol. Cell. Proteomics 2010, 9, 1400-1410.
33. Chung, H., Hong, D. P., Jung, J. Y., Kim, H. J. et al., Comprehensive analysis of differential gene expression profiles on carbon tetrachloride-induced rat liver injury and regeneration. Toxicol. Appl. Pharmacol. 2005, 206, 27-42.
34. Srinivasan, R., Chandrasekar, M. J., Nanjan, M. J., Suresh, B., Antioxidant activity of Caesalpinia digyna root. J. Ethnopharmacol. 2007, 113, 284-291.
35. Palmer, J. W., Tandler, B., Hoppel, C. L., Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J. Biol. Chem. 1977, 252, 8731-8739.
36. Chavez, J. D., Wu, J., Bisson, W., Maier, C. S., Site-specific proteomic analysis of lipoxidation adducts in cardiac mitochondria reveals chemical diversity of 2-alkenal adduction. J. Proteomics 2011, DOI: 10.1016/jprot.2011.03.031.
37. Chavez, J., Chung, W.-G., Miranda, C. L., Singhal, M. et al., Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human thp-1 monocytic cells: protein carbonylation is diminished by ascorbic acid. Chem. Res. Toxicol. 2009, 23, 37-47.
38. Klingenberg, M., The ADP and ATP transport in mitochondria and its carrier. Biochim. Biophys. Acta 2008, 1778, 1978-2021.
39. Gibson, B. W., The human mitochondrial proteome: oxidative stress, protein modifications and oxidative phosphorylation. Int. J. Biochem. Cell Biol. 2005, 37, 927-934.
40. Chung, W.-G., Miranda, C. L., Maier, C. S., Detection of carbonyl-modified proteins in interfibrillar rat mitochondria using N'-aminooxymethylcarbonylhydrazino-D-biotin as an aldehyde/keto-reactive probe in combination with Western blot analysis and tandem mass spectrometry. Electrophoresis 2008, 29, 1317-1324.
41. Yan, L. J., Sohal, R. S., Prevention of flight activity prolongs the life span of the housefly, Musca domestica, and attenuates the age-associated oxidative damage to specific mitochondrial proteins. Free Radic. Biol. Med. 2000, 29, 1143-1150.
42. Majima, E., Koike, H., Hong, Y. M., Shinohara, Y., Terada, H., Characterization of cysteine residues of mitochondrial ADP/ATP carrier with the SH-reagents eosin 5-maleimide and N-ethylmaleimide. J. Biol. Chem. 1993, 268, 22181-22187.
43. Sultana, R., Newman, S. F., Abdul, H. M., Cai, J. et al., Protective effect of D609 against amyloid-beta1-42-induced oxidative modification of neuronal proteins: redox proteomics study. J. Neurosci. Res. 2006, 84, 409-417.
44. Reed, T. T., Pierce, W. M., Markesbery, W. R., Butterfield, D. A., Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD. Brain Res. 2009, 1274, 66-76.
45. Halliwell, B., Gutteridge, T., Free Radic. Biol. Med., Oxford University Press, London 2007.
46. Kuiper, H. C., Miranda, C. L., Sowell, J. D., Stevens, J. F., Mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites are in vivo markers of oxidative stress. J. Biol. Chem. 2008, 283, 17131-17138.
47. Cai, J., Bhatnagar, A., Pierce, W. M., Jr., Protein modification by acrolein: formation and stability of cysteine adducts. Chem. Res. Toxicol. 2009, 22, 708-716.
48. Judge, S., Jang, Y. M., Smith, A., Hagen, T., Leeuwenburgh, C., Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J. 2005, 19, 419-421.